Ömer Faruk Bahçecioğlu (Ömer Faruk Bahçeciȯğlu, Ömer Faruk Bahçecíoğlu)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Methicillin Resistant Staphylococcus Aureus

Combination Therapy

Top Venues

European journal of hospital pharmacy : science and practice

International journal of clinical practice

This page only lists publications with an associated author ORCID identifier.

Publications

Hasan Memiş, Ahmet Çakır, Mefküre DurmuŞ, Selim GÖk, Ömer Faruk Bahçecioğlu
Is sitagliptin effective for the treatment of COVID-19? European journal of hospital pharmacy : science and practice (2021)
Ömer Faruk Bahçecioğlu, Selim Gök, Mefküre Durmuş
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor? European journal of hospital pharmacy : science and practice 28 (2) (2021)
Selim Gök, Ömer Faruk Bahçecioğlu, Mefküre Durmuş, Zeynep Ülkü Gün, Yasemin Ersoy, Zeynep Ayfer Aytemur, Özkan Ulutaş
The safety profile of favipiravir in COVID-19 patients with severe renal impairment. International journal of clinical practice (2021)
Mefküre Durmuş, Ömer Faruk Bahçecioğlu, Selim Gök
Daptomycin in combination with rosuvastatin induced blood creatine phosphokinase elevation. European journal of hospital pharmacy : science and practice 28 (4) (2020)